Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting
– NKTR-255 administered post completion of concurrent chemoradiation and in combination with durvalumab demonstrated statistically significant lymphocyte recovery compared to historical controls at week 8 – – Pharmacodynamic data show NKTR-255 increased NK cell proliferation and markers of NK
Women Health App Market Surges to USD 8 Billion by 2030, Propelled by 14.4% CAGR – Verified Market Reports®
The women’s health app market is driven by the growing awareness of women’s health issues, increasing smartphone penetration, and the rising focus on personalized healthcare solutions. Apps that track menstrual cycles, pregnancy, fitness, and mental health are gaining popularity as women
Metamaterial Market worth $1.38 billion by 2029 – Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 7, 2024 /PRNewswire/ — The Metamaterial market is expected to reach USD 1.38 billion by 2029, up from USD 0.22 billion in 2024, at a CAGR of 44.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The metamaterial market is experiencing significant
Stationary Energy Storage Market is expected to generate a revenue of USD 293.33 Billion by 2031, Globally, at 23.96% CAGR: Verified Market Research®
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, “Stationary Energy Storage Market Size and Forecast,” This comprehensive report offers a deep dive into mar
The Women’s Edge and The Boston Globe Name Melmark to Top 100 Women-Led Businesses in Massachusetts
Melmark President and CEO Rita M. Gardner highlighted for a 7th consecutive year for her significant impact on the state’s economy. ANDOVER, Mass., Nov. 7, 2024 /PRNewswire/ — The Women’s Edge together with its partner The Boston Globe announced Melmark was ranked #25 on its an
Dr. Pedro Martinez-Clark, Founder of Amavita Heart and Vascular™, Partners with LimFlow®, an FDA Approved System for Chronic Limb-Threatening Ischemia Patients
MIAMI, Nov. 7, 2024 /PRNewswire/ — Pedro Martinez-Clark, MD, FACC, a renowned Harvard-trained cardiologist and founder of Amavita Heart and Vascular™, has joined forces with LimFlow® to offer an innovative solution for patients suffering from chronic limb-threatening ischemia (CLTI). This
Women’s Health Conversations Summit in Lake Nona: Sold-Out Event Empowers Women with Expert Insights
LAKE NONA, Fla., Nov. 7, 2024 /PRNewswire/ — The inaugural Lake Nona, FL Women’s Health Conversations Summit, hosted by Dr. Vonda Wright, brings together top health experts and savvy women from across the USA and abroad for a transformative experience on November 8-9, 2024, at the Lake N
MAGNAFLOW GROUP AND CHIP FOOSE ANNOUNCE FORMATION OF FOOSE PERFORMANCE
The Culmination of Two Decades of Partnership, Foose Performance Paves the Way for a New Era of Innovation and Performance OCEANSIDE, Calif., Nov. 7, 2024 /PRNewswire/ — The MagnaFlow Group and Chip Foose today announced the formation of Foose Performance, a new venture formed to push the boun
Canadian Investment Regulatory Organization Trade Resumption – PRMW
TORONTO, Nov. 7, 2024 /CNW/ – Trading resumes in: Company: Primo Water Corporation TSX Symbol: PRMW All Issues: No Resumption (ET): 9:55:02 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented t
FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review
SILVER SPRING, Md., Nov. 7, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the temporary relief of nasal congestion after an a
